Vitalhub Corp.

TSX:VHI.TO

Medical - Healthcare Information Services

Healthcare
$6.66 +0.56%

+$0.04 today

Market cap
$421.84M
Beta
0.77
P/E (TTM)
62.1
EPS (TTM)
$0.12
52W Low $6.67High $14.64

Volume 0.23M

Average 0.41M

VHI.TO Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Vitalhub Corp.TSX: VHI.TO

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of CA$9.44M rose 123.2% year over year, ahead of the +109.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 5.1% from the prior quarter. Over 3 fiscal years it compounded at +66.5% a year.

Context

  • Cost of revenue amounted to 29.8% of revenue in FY2025, up 10.7 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +123.2% holds above the trailing-twelve-month pace of +109.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$9.44M-5.1% QoQ
Last fiscal yearDec 2025
CA$32.46M+147.8% YoY
LTMMar 2026
CA$30.05M+109.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+123.2%——
1 year+147.8%——
3-year CAGR+66.5%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

CAD · from the income statement

Latest · FY2025
32.46M CAD
Year-over-year change
+147.8%
4-year CAGR
+57.8%

Cost of Revenue vs competitors

How VHI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +109.3% is the 2nd highest of 7, against a peer median of +48.0%.
  • Cost of revenue amounts to 25.2% of revenue for VHI.TO, versus a peer median of 55.9%.
VHI.TO Competitors
Cost of Revenue for VHI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$319.93M CAD+55.9%+24.4%62.7%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$218.14M CAD+40.1%+0.7%68.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$128.47M USD-10.2%-13.4%49.1%
VHI.TOVitalhub Corp.LTM Mar 2026CA$30.05M CAD+109.3%+66.5%25.2%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$26.53M CAD+101.5%+46.4%39.9%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$12.97M USD+17.0%+63.9%25.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$4.95M CAD+344.3%+123.1%179.2%
Peer median (excluding VHI.TO) —+48.0%+35.4%55.9%

Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.66M39.97M52.51M68.59M108.97M
Cost of Revenue5.24M7.03M9.7M13.1M32.46M
Gross Profit19.43M32.94M42.81M55.49M76.51M
Gross Margin78.8%82.4%81.5%80.9%70.2%
Research & Development6.05M10.43M12.17M15.23M28.95M
Selling, General & Admin10.41M13.97M18.8M24.56M35.39M
Operating Expenses19.13M28.28M42.81M45.75M64.34M
Depreciation & Amortization2.68M3.87M4.98M5.96M11.08M
EBITDA1.12M5.25M10.38M11.9M23.25M
EBITDA Margin4.5%13.1%19.8%17.4%21.3%
Operating Income324.33K4.66M6.86M9.74M12.17M
Operating Margin1.3%11.7%13.1%14.2%11.2%
Interest Income29.55K0489.57K1.95M2.42M
Interest Expense82.43K70.35K71.98K43.01K70.35K
Other Income / Expenses(1.94M)(6.28M)(1.53M)(3.85M)(6.27M)
Income Before Tax(1.61M)1.31M5.33M5.9M5.9M
Pre-Tax Margin-6.5%3.3%10.1%8.6%5.4%
Income Tax Expense333.08K92.08K778.25K2.9M(209.56K)
Net Income(1.95M)1.21M4.55M3M6.11M
Net Margin-7.9%3.0%8.7%4.4%5.6%
EPS (Basic)(0.05)0.030.100.060.10
EPS (Diluted)(0.05)0.030.100.060.10
Weighted Avg Shares36.4M41.49M43.65M49.2M58.54M
Weighted Avg Shares (Diluted)36.4M42.56M46.6M50.93M60.29M

Vitalhub Corp.

TSX:VHI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.